Although alterations in SPP1 gene have been reported but poorly represented in bladder cancer (2.19% of 411 bladder cases [98], we can hypothesise that NOTCH3-triggered molecular mechanism may be the prevailing one. The gene discussed is NOTCH3; the disease is urinary bladder carcinoma.